Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 4/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | CA1 | P00915 | 2/20 | 0.70 |
| ▸ | CA2 | P00918 | 2/20 | 0.70 |
| ▸ | CA12 | O43570 | 1/20 | 0.70 |
| ▸ | CA4 | P22748 | 1/20 | 0.70 |
| ▸ | CA6 | P23280 | 1/20 | 0.70 |
| ▸ | CA7 | P43166 | 1/20 | 0.70 |
| ▸ | TPMT | P51580 | 1/20 | 0.70 |
| ▸ | CA9 | Q16790 | 1/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29415167 | 1.00 | MAPK1 (0.77) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 | |
| Hydrochloric Acid SCHEMBL5154533 | 0.98 | MAPK1 (0.74) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL17656092 | 0.92 | MAPK1 (0.68) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL17184498 | 0.89 | TSHR (0.73) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL24812339 | 0.88 | MAPK1 (0.62) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 | |
| Trifluoroacetic Acid SCHEMBL4440333 | 0.88 | MAPK1 (0.62) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL6944861 | 0.88 | MAPK1 (1.00) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL11401711 | 0.86 | PARP10 (0.67) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL29824542 | 0.86 | KDM4E (0.61) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL16533679 | 0.86 | MAPK1 (0.74) | MAPK1TSHRCYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1069 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005557-A | Application of veratramine in preparing lysosome trapping inhibiting preparation and antiviral preparation | 浙江大学台州研究院 | 2026-05-12 | — | — | CN | claimed |
| US-12575248-B2 | Zinc oxide nanomaterial and preparation method thereof and semiconductor device | TCL TECHNOLOGY GROUP CORPORATION (CN) | 2026-03-10 | — | — | US | claimed |
| EP-4559480-A1 | USE OF JUN INHIBITOR IN PREPARING MEDICAMENT FOR TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION | Fuwai Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College (CN) | 2025-05-28 | — | — | EP | claimed |
| CN-119708111-A | Method for synthesizing cyclopamine from veratramine | 华东师范大学 | 2025-03-28 | — | — | CN | claimed |
| CN-119667065-A | Kit and method for screening 74 toxic drugs in blood | 华中科技大学同济医学院附属同济医院 | 2025-03-21 | — | — | CN | claimed |
| CN-116375789-B | Antitumor compound, preparation method thereof, pharmaceutical composition and application | 北京大学第一医院 | 2025-03-21 | — | — | CN | claimed |
| CN-119424452-A | Application of steroid alkaloid from fritillaria hupehensis in preparation of immunosuppressive drugs | 中南民族大学 | 2025-02-14 | — | — | CN | claimed |
| WO-2024027593-A9 | USE OF JUN INHIBITOR IN PREPARING MEDICAMENT FOR TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION | 中国医学科学院阜外医院 | 2025-02-13 | — | — | WO | claimed |
| EP-4167307-B1 | ZINC OXIDE NANOMATERIAL AND PREPARATION METHOD THEREFOR, AND SEMICONDUCTOR DEVICE | TCL TECH GROUP CORP (CN) | 2025-02-05 | — | — | EP | claimed |
| CN-119215056-A | Combined anti-tumor composition, anti-tumor combination product and application thereof | 北京大学第一医院 | 2024-12-31 | — | — | CN | claimed |
| WO-2003057183-A1 | COMPOSITION FOR SKIN WHITENING | LG HOUSEHOLD & HEALTHCARE CO., LTD. (KR) | 2003-07-17 | — | — | WO | claimed |
| US-20030114393-A1 | Use of steroidal alkaloids to reverse multidrug resistance | YEDA RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2003-06-19 | — | — | US | claimed |
| US-20030105081-A1 | Heterocyclic compounds as ligands of the GABAA receptor | PFIZER INC | 2003-06-05 | — | — | US | claimed |
| EP-1274445-A2 | USE OF STEROIDAL ALKALOIDS TO REVERSE MULTIDRUG RESISTANCE | YEDA RESEARCH AND DEVELOPMENT Co. LTD. (IL) | 2003-01-15 | — | — | EP | claimed |
| WO-2002028353-A2 | PHOSPHATE TRANSPORT INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2002-04-11 | — | — | WO | claimed |
| WO-2001049279-A2 | USE OF STEROIDAL ALKALOIDS TO REVERSE MULTIDRUG RESISTANCE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2001-07-12 | — | — | WO | claimed |
| US-4970297-A | CONTAINING ISOXAZOLE RING | SYNTEX (U.S.A.) INC. (US) | 1990-11-13 | — | — | US | claimed |
| EP-0030009-B1 | NEW DERIVATIVES OF THE 9-CIS-6,6'-DIAPO-PSI,PSI-CAROTENEDIOIC ACID, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | Simes S.p.A. (IT) | 1983-05-11 | — | — | EP | claimed |
| US-4304935-A | Production of 1-phenyl-3-cyanoureas | REXOLIN CHEMICALS AB (SE) | 1981-12-08 | — | — | US | claimed |
| EP-0030009-A1 | New derivatives of the 9-cis-6,6'-diapo-psi,psi-carotenedioic acid, preparation thereof and pharmaceutical compositions containing same | Simes S.p.A. (IT) | 1981-06-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105081-A1 | Heterocyclic compounds as ligands of the GABAA receptor | GABRB1, GABRP, GABRA1 | MAPK1 3432/4885TSHR 252/4885CYP1A2 385/4885 |
| US-12575248-B2 | Zinc oxide nanomaterial and preparation method thereof and semiconductor device | ZRANB2, ZKSCAN2, SLC39A3 | MAPK1 3601/4885TSHR 1082/4885CYP1A2 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.